Oral Answers to Questions

Carla Lockhart Excerpts

Tuesday 20th October 2026 Commons Chamber

[Yvette Cooper]

My hon. Friend makes an important point about the importance of improving prostate cancer treatment, which affects so many men across the UK. We are investing £2.8 million to expand access to focal therapy in specialist centres in England, and NICE will look at the progress that is being made. We would of course be keen to work with the Scottish Government on this, and for them to be able to see the same results. It is important that we continue to improve treatment.

[Carla Lockhart (Upper Bann) (DUP)]

Scott, aged 30, is a dad, a son, a partner and a much-loved member of the Banbridge community, but he is battling grade 4 brain cancer. Brain cancer is the biggest killer of young people under the age of 40 in the UK, and survival rates are lower than the average across all cancers. Access to clinical trials is negligible, with only 2% of brain tumour patients successfully accessing them. Will the Secretary of State expand brain tumour clinical trials across the United Kingdom, and ensure fair access across all nations?

[Yvette Cooper]

I pay tribute to the hon. Lady’s constituent, who is obviously undergoing the most difficult of circumstances, and it is exactly because this is such a devastating condition that we have introduced a three-month rapid review of all the research and barriers to getting more patients into trials. We are of course keen to continue to work with the devolved Governments on this, because the research benefits us all right across the United Kingdom. We will be drawing up a framework to get drugs more quickly into trials, and to get more patients into those trials.